Cargando…

A comprehensive evaluation of 181 reported CHST6 variants in patients with macular corneal dystrophy

Macular corneal dystrophy (MCD) is an autosomal recessive disease featured by bilateral progressive stromal clouding and loss of vision, consequently necessitating corneal transplantation. Variants in CHST6 gene have been recognized as the most critical genetic components in MCD. Although many CHST6...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jing, Wu, Dan, Li, Yue, Fan, Yidan, Dai, Yiqin, Xu, Jianjiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382428/
https://www.ncbi.nlm.nih.gov/pubmed/30716718
http://dx.doi.org/10.18632/aging.101807
_version_ 1783396670114889728
author Zhang, Jing
Wu, Dan
Li, Yue
Fan, Yidan
Dai, Yiqin
Xu, Jianjiang
author_facet Zhang, Jing
Wu, Dan
Li, Yue
Fan, Yidan
Dai, Yiqin
Xu, Jianjiang
author_sort Zhang, Jing
collection PubMed
description Macular corneal dystrophy (MCD) is an autosomal recessive disease featured by bilateral progressive stromal clouding and loss of vision, consequently necessitating corneal transplantation. Variants in CHST6 gene have been recognized as the most critical genetic components in MCD. Although many CHST6 variants have been described until now, the detailed mechanisms underlying MCD are still far from understood. In this study, we integrated all the reported CHST6 variants described in 408 MCD cases, and performed a comprehensive evaluation to better illustrate the causality of these variants. The results showed that majority of these variants (165 out of 181) could be classified as pathogenic or likely pathogenic. Interestingly, we also identified several disease causal variants with ethnic specificity. In addition, the results underscored the strong correlation between mutant frequency and residue conservation in the general population (Spearman’s correlation coefficient = -0.311, P = 1.20E-05), thus providing potential candidate targets for further genetic manipulation. The current study highlighted the demand of further functional investigations to evaluate the causality of CHST6 variants, so as to promote earlier accurate diagnosis of MCD and future development of potential targets for genetic therapy.
format Online
Article
Text
id pubmed-6382428
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Impact Journals
record_format MEDLINE/PubMed
spelling pubmed-63824282019-02-27 A comprehensive evaluation of 181 reported CHST6 variants in patients with macular corneal dystrophy Zhang, Jing Wu, Dan Li, Yue Fan, Yidan Dai, Yiqin Xu, Jianjiang Aging (Albany NY) Research Paper Macular corneal dystrophy (MCD) is an autosomal recessive disease featured by bilateral progressive stromal clouding and loss of vision, consequently necessitating corneal transplantation. Variants in CHST6 gene have been recognized as the most critical genetic components in MCD. Although many CHST6 variants have been described until now, the detailed mechanisms underlying MCD are still far from understood. In this study, we integrated all the reported CHST6 variants described in 408 MCD cases, and performed a comprehensive evaluation to better illustrate the causality of these variants. The results showed that majority of these variants (165 out of 181) could be classified as pathogenic or likely pathogenic. Interestingly, we also identified several disease causal variants with ethnic specificity. In addition, the results underscored the strong correlation between mutant frequency and residue conservation in the general population (Spearman’s correlation coefficient = -0.311, P = 1.20E-05), thus providing potential candidate targets for further genetic manipulation. The current study highlighted the demand of further functional investigations to evaluate the causality of CHST6 variants, so as to promote earlier accurate diagnosis of MCD and future development of potential targets for genetic therapy. Impact Journals 2019-02-04 /pmc/articles/PMC6382428/ /pubmed/30716718 http://dx.doi.org/10.18632/aging.101807 Text en Copyright: © 2019 Zhang et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Zhang, Jing
Wu, Dan
Li, Yue
Fan, Yidan
Dai, Yiqin
Xu, Jianjiang
A comprehensive evaluation of 181 reported CHST6 variants in patients with macular corneal dystrophy
title A comprehensive evaluation of 181 reported CHST6 variants in patients with macular corneal dystrophy
title_full A comprehensive evaluation of 181 reported CHST6 variants in patients with macular corneal dystrophy
title_fullStr A comprehensive evaluation of 181 reported CHST6 variants in patients with macular corneal dystrophy
title_full_unstemmed A comprehensive evaluation of 181 reported CHST6 variants in patients with macular corneal dystrophy
title_short A comprehensive evaluation of 181 reported CHST6 variants in patients with macular corneal dystrophy
title_sort comprehensive evaluation of 181 reported chst6 variants in patients with macular corneal dystrophy
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382428/
https://www.ncbi.nlm.nih.gov/pubmed/30716718
http://dx.doi.org/10.18632/aging.101807
work_keys_str_mv AT zhangjing acomprehensiveevaluationof181reportedchst6variantsinpatientswithmacularcornealdystrophy
AT wudan acomprehensiveevaluationof181reportedchst6variantsinpatientswithmacularcornealdystrophy
AT liyue acomprehensiveevaluationof181reportedchst6variantsinpatientswithmacularcornealdystrophy
AT fanyidan acomprehensiveevaluationof181reportedchst6variantsinpatientswithmacularcornealdystrophy
AT daiyiqin acomprehensiveevaluationof181reportedchst6variantsinpatientswithmacularcornealdystrophy
AT xujianjiang acomprehensiveevaluationof181reportedchst6variantsinpatientswithmacularcornealdystrophy
AT zhangjing comprehensiveevaluationof181reportedchst6variantsinpatientswithmacularcornealdystrophy
AT wudan comprehensiveevaluationof181reportedchst6variantsinpatientswithmacularcornealdystrophy
AT liyue comprehensiveevaluationof181reportedchst6variantsinpatientswithmacularcornealdystrophy
AT fanyidan comprehensiveevaluationof181reportedchst6variantsinpatientswithmacularcornealdystrophy
AT daiyiqin comprehensiveevaluationof181reportedchst6variantsinpatientswithmacularcornealdystrophy
AT xujianjiang comprehensiveevaluationof181reportedchst6variantsinpatientswithmacularcornealdystrophy